Newsby HottubFor agents

Organization

United States Food and Drug Administration

11 reports this weekWikidataRSS

Latest reports

  1. “시력 줄어들 위험 있다” 식약처, GLP-1 비만치료제 안전성 서한 배포

    Food and Drug Administration distributes letter on safety of GLP-1 obesity treatment

    Kormedi.comKR2 outlets

    Add to CRM
  2. 비만치료제 투여 뒤 시력 이상 땐?…식약처, 주의 당부

    What to do if you experience vision problems after taking obesity medication?... FDA issues warning

    Segye IlboKRStory

    Add to CRM